An enantiomer-selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine, and liver microsomes

David E. Moody, Shen Nan Lin, Yan Chang, Lolita Lamm, Mark K. Greenwald, Mahmoud Ahmed

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

A liquid chromatography-electrospray ionization-tandem mass spectrometry method has been developed and validated to detect (R)- and (S)-methadone and (R)- and (S)-2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) in human plasma with cross-validation to urine and liver microsomes. Use of deuterated internal standards and liquid-liquid extraction coupled with chiral separation provided baseline separation with a lower limit of quantitation (LLOQ) of 2.5 ng/mL. The LLOQ was established from comparison of signal in blanks from six different sources per matrix with the same sources fortified at the LLOQ (none exceeded 19% of LLOQ) and precision and accuracy at the LLOQ determined in the same six sources per matrix. The assay was precise (% coefficients of variation within 13.8%) and accurate (% targets within 15%) in all three matrices. No interference was seen from addition of other psychoactive drugs. Stability was determined in plasma (24 h at room temperature, 321 days at -20°C, 3 freeze-thaw cycles); processed plasma samples (5 days at -20°C, 12 days on autosampler); urine (24 h at room temperature); and stock solutions (20 h at room temperature, 61 days at -20°C). Applications of varying degree are presented for each matrix. Plasma from five subjects maintained on 100 mg oral methadone per day permitted comparison of the pharmacokinetics of the enantiomers. The t1/2 of (R)-methadone was significantly longer than for (S)-methadone, and (S)-methadone was more tightly protein bound. The C max, AUC, Cmin, and % protein bound of (S)-EDDP were significantly greater than (R)-EDDP, while the t1/2 of (R)-EDDP was significantly greater than (S)-EDDP. In spot urines, (R)- was higher than (S)-methadone, and (S)- was generally higher than (R)-EDDP. (R)- and (S)-EDDP production was detected after incubation of therapeutic concentrations of racemic methadone with human liver microsomes, and (S)-EDDP production was twofold greater than (R)-EDDP in three human placental microsomes incubated with racemic methadone.

Original languageEnglish (US)
Pages (from-to)208-219
Number of pages12
JournalJournal of Analytical Toxicology
Volume32
Issue number3
StatePublished - Apr 2008

Fingerprint

Plasma (human)
Enantiomers
Methadone
Liquid chromatography
Liver Microsomes
Tandem Mass Spectrometry
Liquid Chromatography
Liver
urine
Mass spectrometry
liquid chromatography
mass spectrometry
Urine
Plasmas
plasma
matrix
Proteins
Electrospray ionization
Pharmacokinetics
Liquids

ASJC Scopus subject areas

  • Analytical Chemistry
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

An enantiomer-selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine, and liver microsomes. / Moody, David E.; Lin, Shen Nan; Chang, Yan; Lamm, Lolita; Greenwald, Mark K.; Ahmed, Mahmoud.

In: Journal of Analytical Toxicology, Vol. 32, No. 3, 04.2008, p. 208-219.

Research output: Contribution to journalArticle

@article{8620b167aa7944819b5a3f1f12565e5a,
title = "An enantiomer-selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine, and liver microsomes",
abstract = "A liquid chromatography-electrospray ionization-tandem mass spectrometry method has been developed and validated to detect (R)- and (S)-methadone and (R)- and (S)-2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) in human plasma with cross-validation to urine and liver microsomes. Use of deuterated internal standards and liquid-liquid extraction coupled with chiral separation provided baseline separation with a lower limit of quantitation (LLOQ) of 2.5 ng/mL. The LLOQ was established from comparison of signal in blanks from six different sources per matrix with the same sources fortified at the LLOQ (none exceeded 19{\%} of LLOQ) and precision and accuracy at the LLOQ determined in the same six sources per matrix. The assay was precise ({\%} coefficients of variation within 13.8{\%}) and accurate ({\%} targets within 15{\%}) in all three matrices. No interference was seen from addition of other psychoactive drugs. Stability was determined in plasma (24 h at room temperature, 321 days at -20°C, 3 freeze-thaw cycles); processed plasma samples (5 days at -20°C, 12 days on autosampler); urine (24 h at room temperature); and stock solutions (20 h at room temperature, 61 days at -20°C). Applications of varying degree are presented for each matrix. Plasma from five subjects maintained on 100 mg oral methadone per day permitted comparison of the pharmacokinetics of the enantiomers. The t1/2 of (R)-methadone was significantly longer than for (S)-methadone, and (S)-methadone was more tightly protein bound. The C max, AUC, Cmin, and {\%} protein bound of (S)-EDDP were significantly greater than (R)-EDDP, while the t1/2 of (R)-EDDP was significantly greater than (S)-EDDP. In spot urines, (R)- was higher than (S)-methadone, and (S)- was generally higher than (R)-EDDP. (R)- and (S)-EDDP production was detected after incubation of therapeutic concentrations of racemic methadone with human liver microsomes, and (S)-EDDP production was twofold greater than (R)-EDDP in three human placental microsomes incubated with racemic methadone.",
author = "Moody, {David E.} and Lin, {Shen Nan} and Yan Chang and Lolita Lamm and Greenwald, {Mark K.} and Mahmoud Ahmed",
year = "2008",
month = "4",
language = "English (US)",
volume = "32",
pages = "208--219",
journal = "Journal of Analytical Toxicology",
issn = "0146-4760",
publisher = "Preston Publications",
number = "3",

}

TY - JOUR

T1 - An enantiomer-selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine, and liver microsomes

AU - Moody, David E.

AU - Lin, Shen Nan

AU - Chang, Yan

AU - Lamm, Lolita

AU - Greenwald, Mark K.

AU - Ahmed, Mahmoud

PY - 2008/4

Y1 - 2008/4

N2 - A liquid chromatography-electrospray ionization-tandem mass spectrometry method has been developed and validated to detect (R)- and (S)-methadone and (R)- and (S)-2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) in human plasma with cross-validation to urine and liver microsomes. Use of deuterated internal standards and liquid-liquid extraction coupled with chiral separation provided baseline separation with a lower limit of quantitation (LLOQ) of 2.5 ng/mL. The LLOQ was established from comparison of signal in blanks from six different sources per matrix with the same sources fortified at the LLOQ (none exceeded 19% of LLOQ) and precision and accuracy at the LLOQ determined in the same six sources per matrix. The assay was precise (% coefficients of variation within 13.8%) and accurate (% targets within 15%) in all three matrices. No interference was seen from addition of other psychoactive drugs. Stability was determined in plasma (24 h at room temperature, 321 days at -20°C, 3 freeze-thaw cycles); processed plasma samples (5 days at -20°C, 12 days on autosampler); urine (24 h at room temperature); and stock solutions (20 h at room temperature, 61 days at -20°C). Applications of varying degree are presented for each matrix. Plasma from five subjects maintained on 100 mg oral methadone per day permitted comparison of the pharmacokinetics of the enantiomers. The t1/2 of (R)-methadone was significantly longer than for (S)-methadone, and (S)-methadone was more tightly protein bound. The C max, AUC, Cmin, and % protein bound of (S)-EDDP were significantly greater than (R)-EDDP, while the t1/2 of (R)-EDDP was significantly greater than (S)-EDDP. In spot urines, (R)- was higher than (S)-methadone, and (S)- was generally higher than (R)-EDDP. (R)- and (S)-EDDP production was detected after incubation of therapeutic concentrations of racemic methadone with human liver microsomes, and (S)-EDDP production was twofold greater than (R)-EDDP in three human placental microsomes incubated with racemic methadone.

AB - A liquid chromatography-electrospray ionization-tandem mass spectrometry method has been developed and validated to detect (R)- and (S)-methadone and (R)- and (S)-2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) in human plasma with cross-validation to urine and liver microsomes. Use of deuterated internal standards and liquid-liquid extraction coupled with chiral separation provided baseline separation with a lower limit of quantitation (LLOQ) of 2.5 ng/mL. The LLOQ was established from comparison of signal in blanks from six different sources per matrix with the same sources fortified at the LLOQ (none exceeded 19% of LLOQ) and precision and accuracy at the LLOQ determined in the same six sources per matrix. The assay was precise (% coefficients of variation within 13.8%) and accurate (% targets within 15%) in all three matrices. No interference was seen from addition of other psychoactive drugs. Stability was determined in plasma (24 h at room temperature, 321 days at -20°C, 3 freeze-thaw cycles); processed plasma samples (5 days at -20°C, 12 days on autosampler); urine (24 h at room temperature); and stock solutions (20 h at room temperature, 61 days at -20°C). Applications of varying degree are presented for each matrix. Plasma from five subjects maintained on 100 mg oral methadone per day permitted comparison of the pharmacokinetics of the enantiomers. The t1/2 of (R)-methadone was significantly longer than for (S)-methadone, and (S)-methadone was more tightly protein bound. The C max, AUC, Cmin, and % protein bound of (S)-EDDP were significantly greater than (R)-EDDP, while the t1/2 of (R)-EDDP was significantly greater than (S)-EDDP. In spot urines, (R)- was higher than (S)-methadone, and (S)- was generally higher than (R)-EDDP. (R)- and (S)-EDDP production was detected after incubation of therapeutic concentrations of racemic methadone with human liver microsomes, and (S)-EDDP production was twofold greater than (R)-EDDP in three human placental microsomes incubated with racemic methadone.

UR - http://www.scopus.com/inward/record.url?scp=41649103033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41649103033&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 208

EP - 219

JO - Journal of Analytical Toxicology

JF - Journal of Analytical Toxicology

SN - 0146-4760

IS - 3

ER -